Voyager Therapeutics Investor Relations Material
Latest events
Q4 2024
Voyager Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Voyager Therapeutics Inc
Access all reports
Voyager Therapeutics Inc. is a biotechnology company focused on developing gene therapies for the treatment of severe neurological diseases. The company leverages its proprietary platform to create therapies designed to deliver genetic material directly to targeted cells in the brain and other parts of the nervous system. Voyager's research and development efforts focus on treating conditions such as Parkinson’s disease, Huntington’s disease, and other central nervous system disorders. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
VYGR
Country
🇺🇸 United States